{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P10275",
      "entity_text" : "AR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02604",
      "entity_text" : "AR inhibitors",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "AR inhibitors that reduce the effect of inflammatory responses due to cytokine secretion and ROS production can be used to inhibit the activity of AR and hence the ocular complications [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-04T14:47:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:43:56Z",
  "trigger" : "inhibit",
  "evidence" : [ "AR inhibitors that reduce the effect of inflammatory responses due to cytokine secretion and ROS production can be used to inhibit the activity of AR" ],
  "pmc_id" : "6916131",
  "score" : 0
}